COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses

Background: Vaccine hesitancy represents one of the major global health issues around the world. We examined the perception, attitude, perceived barriers and facilitation measures of receiving the COVID-19 vaccine in a Chinese population with free vaccine choices (Sinovac [Coronavac] vs. BioNTech/Fo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Martin C. S. Wong, Eliza L. Y. Wong, Annie W. L. Cheung, Junjie Huang, Christopher K. C. Lai, Eng Kiong Yeoh, Paul K. S. Chan
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	COVID-19 vaccine hesitancy vaccine choice barriers incentives compulsory vaccination Medicine R
Acceso en línea:	https://doaj.org/article/ea5d7dbb70cb431aaa70fdd01ef5d307
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ea5d7dbb70cb431aaa70fdd01ef5d307
record_format	dspace
spelling	oai:doaj.org-article:ea5d7dbb70cb431aaa70fdd01ef5d3072021-11-25T19:10:32ZCOVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses10.3390/vaccines91112502076-393Xhttps://doaj.org/article/ea5d7dbb70cb431aaa70fdd01ef5d3072021-10-01T00:00:00Zhttps://www.mdpi.com/2076-393X/9/11/1250https://doaj.org/toc/2076-393XBackground: Vaccine hesitancy represents one of the major global health issues around the world. We examined the perception, attitude, perceived barriers and facilitation measures of receiving the COVID-19 vaccine in a Chinese population with free vaccine choices (Sinovac [Coronavac] vs. BioNTech/Fosun [Comirnaty]) and adequate doses. Method: We conducted a random telephone survey of the general population in 1195 subjects aged 18 years or above from 23 April 2021 to 8 May 2021 after two months of vaccine rollout. A descriptive analysis of the levels of enabling factors, obstacles and perception of COVID-19 vaccination was conducted using ANOVA and Chi-square tests for trend. Results: Only 10.1% and 13.5% had received one and two COVID-19 vaccine doses, respectively. Among those who had not received any COVID-19 vaccine (75.4%), only 25.1% expressed their intention to receive in the coming 6 months. The barriers with the highest scores included “having heard of cases with serious adverse events or death after vaccination” (score: 8.17 out 10, 95% C.I. 7.99, 8.35), “lack of confidence on governmental recommendations” (7.69, 95% C.I. 7.47, 7.91), and “waiting for a better vaccine” (7.29, 95% C.I. 7.07, 7.52). The highest score for the impact of various incentives for vaccination was for “vaccine passports for overseas travel” (4.44, 95% C.I. 4.18, 4.71). Conclusions: Vaccine hesitancy is commonly observed in this Chinese population despite adequate provision of vaccine doses and choices. No single incentive is strong enough to promote vaccination, and multiple facilitation measures for different groups of population are needed to encourage vaccine uptake. Active clarification and promotion by medical professionals together with a variety of incentives are needed to drive vaccine uptake.Martin C. S. WongEliza L. Y. WongAnnie W. L. CheungJunjie HuangChristopher K. C. LaiEng Kiong YeohPaul K. S. ChanMDPI AGarticleCOVID-19vaccine hesitancyvaccine choicebarriersincentivescompulsory vaccinationMedicineRENVaccines, Vol 9, Iss 1250, p 1250 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 vaccine hesitancy vaccine choice barriers incentives compulsory vaccination Medicine R
spellingShingle	COVID-19 vaccine hesitancy vaccine choice barriers incentives compulsory vaccination Medicine R Martin C. S. Wong Eliza L. Y. Wong Annie W. L. Cheung Junjie Huang Christopher K. C. Lai Eng Kiong Yeoh Paul K. S. Chan COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
description	Background: Vaccine hesitancy represents one of the major global health issues around the world. We examined the perception, attitude, perceived barriers and facilitation measures of receiving the COVID-19 vaccine in a Chinese population with free vaccine choices (Sinovac [Coronavac] vs. BioNTech/Fosun [Comirnaty]) and adequate doses. Method: We conducted a random telephone survey of the general population in 1195 subjects aged 18 years or above from 23 April 2021 to 8 May 2021 after two months of vaccine rollout. A descriptive analysis of the levels of enabling factors, obstacles and perception of COVID-19 vaccination was conducted using ANOVA and Chi-square tests for trend. Results: Only 10.1% and 13.5% had received one and two COVID-19 vaccine doses, respectively. Among those who had not received any COVID-19 vaccine (75.4%), only 25.1% expressed their intention to receive in the coming 6 months. The barriers with the highest scores included “having heard of cases with serious adverse events or death after vaccination” (score: 8.17 out 10, 95% C.I. 7.99, 8.35), “lack of confidence on governmental recommendations” (7.69, 95% C.I. 7.47, 7.91), and “waiting for a better vaccine” (7.29, 95% C.I. 7.07, 7.52). The highest score for the impact of various incentives for vaccination was for “vaccine passports for overseas travel” (4.44, 95% C.I. 4.18, 4.71). Conclusions: Vaccine hesitancy is commonly observed in this Chinese population despite adequate provision of vaccine doses and choices. No single incentive is strong enough to promote vaccination, and multiple facilitation measures for different groups of population are needed to encourage vaccine uptake. Active clarification and promotion by medical professionals together with a variety of incentives are needed to drive vaccine uptake.
format	article
author	Martin C. S. Wong Eliza L. Y. Wong Annie W. L. Cheung Junjie Huang Christopher K. C. Lai Eng Kiong Yeoh Paul K. S. Chan
author_facet	Martin C. S. Wong Eliza L. Y. Wong Annie W. L. Cheung Junjie Huang Christopher K. C. Lai Eng Kiong Yeoh Paul K. S. Chan
author_sort	Martin C. S. Wong
title	COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
title_short	COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
title_full	COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
title_fullStr	COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
title_full_unstemmed	COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
title_sort	covid-19 vaccine hesitancy in a city with free choice and sufficient doses
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/ea5d7dbb70cb431aaa70fdd01ef5d307
work_keys_str_mv	AT martincswong covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses AT elizalywong covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses AT anniewlcheung covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses AT junjiehuang covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses AT christopherkclai covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses AT engkiongyeoh covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses AT paulkschan covid19vaccinehesitancyinacitywithfreechoiceandsufficientdoses
_version_	1718410252214337536

COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses

Ejemplares similares